Can Nutanix Turn Itself Around After This Dismal Q3 Report?
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Nutanix Inc. (NASDAQ: NTNX) shares tumbled after it released its most recent quarterly results late on Thursday. The cloud computing software firm posted a net loss of $0.56 per share and $287.6 million in revenue, while consensus estimates had called for a net loss of $0.60 per share and $297.22 million in revenue. The fiscal third quarter of last year reportedly had a net loss of $0.21 per share and $289.41 million in revenue.
Software and support revenues increased 17% year over year to $265.8 million, up from $226.8 million.
During the most recent quarter, billings decreased slightly to $346.0 million from last year’s billings of $351.2 million. At the same time, software and support billings increased 11% year over year to $324.2 million.
For the fiscal third quarter, deferred revenues increased 55% year over year to $838.3 million.
Dheeraj Pandey, board chair, founder and CEO of Nutanix, commented:
While we faced a top-line impact in our third quarter as we continue to execute our strategic shift toward a recurring revenue business model, our strong foundation and commitment to our customers position us well for the long term. Successful businesses are built over time on a bedrock of exceptional products, outstanding customer support and talented and committed employees. With solid sales hiring in Q3 and increased adoption of our AHV hypervisor, indicating a strong product and enthusiastic customers, I truly believe Nutanix has that foundation in place.
Looking ahead to the fiscal fourth quarter, the company expects to see a net loss per share of $0.65 and revenues in the range of $280 million to $310 million. Consensus estimates call for a net loss of $0.48 per share and $334.23 million in revenue for the quarter.
Shares of Nutanix were last seen down about 15% at $27.71, in a 52-week range of $25.50 to $64.87. The consensus price target is $47.32.
Contact [email protected] for any questions or corrections.






